Neglected diseases and drug discovery - no. 14

This is a state-of-the-art review of drug discovery in respect of NTDs, highlighting best practice to guide the ongoing drug discovery effort.

All the major diseases such as malaria, trypanosomatids and TB are covered, with a review of each disease and established compounds, new mechanistic classes and new horizons.